Aluminum, Blood Test
This test measures the concentration of aluminum in a whole blood sample. Quest associates aluminum accumulation with encephalopathy in patients undergoing prolonged hemodialysis for renal failure.
About this test
Aluminum is measured in whole blood using inductively coupled plasma/mass spectrometry. Quest describes aluminum as a cause of encephalopathy identified in patients undergoing prolonged hemodialysis for renal failure, where the metal accumulates in the blood.
In renal failure, Quest notes that the ability to filter and excrete aluminum is lost, allowing it to accumulate first in the blood and eventually in the brain and bone. The sample is collected in an EDTA trace metal-free (royal blue-top) tube, and Quest lists a preparation instruction for this test, which appears with the test details.
Test details
| Collection | Quest patient service center |
|---|
Quest resources
Additional details
What this test looks at
The test reports a single value: the concentration of aluminum in whole blood, measured with a trace metal-free collection process to avoid contamination. Quest ties elevated aluminum specifically to the setting of prolonged hemodialysis for renal failure.
This test isn't part of the Celio Health store at the moment, so it can't be ordered or requested here. The test menu lists everything that can.
Laboratory results should always be interpreted by a licensed clinician who knows your health history. This page is information about a test, not medical advice.
Frequently asked questions
What does this test measure?
It measures the concentration of aluminum in whole blood using inductively coupled plasma/mass spectrometry.
How is the sample collected?
The test uses a 2 mL whole blood sample collected in an EDTA trace metal-free (royal blue-top) tube.
Do I need to prepare for this test?
Yes. Quest lists a preparation instruction for this test, which appears with the test details. Follow any additional instructions your ordering clinician provides.
In what setting is aluminum accumulation a concern?
Quest describes aluminum as a cause of encephalopathy in patients undergoing prolonged hemodialysis for renal failure, where the ability to filter and excrete aluminum is lost.